2m 2m 2m 2m 2m 2m 2m
VERASTEM (VSTM)
NASDAQ
$3.77-$0.04 (-1.05%)
Price as of Jun 03, 2026 7:15 PM EDT- $380.5MMarket Cap
- -35.42%1-Year Change
- BiotechnologyIndustry
VERASTEM (VSTM)
$3.77-$0.04 (-1.05%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 30.9M +209.14% | 10.0M +285.21% | 2.6M 0.00% | 2.6M +26.45% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 30.9M +209.14% | 10.0M +285.21% | 2.6M 0.00% | 2.6M +26.45% | |
Sales and Marketing Expense | 81.1M +86.02% | 43.6M +41.96% | 30.7M +23.04% | 25.0M +3.57% | |
Research and Development Expense | -114.6M +40.90% | -81.3M +32.56% | -61.4M +21.36% | -50.6M +28.49% | |
Depreciation and Amortization Expense | 698,000 +2,584.62% | 26,000 -58.06% | 62,000 -92.18% | 793,000 0.00% | |
Total Operating Expenses | 201.0M +60.89% | 125.0M +35.70% | 92.1M +21.91% | 75.5M +19.02% | |
Operating Profit | -170.1M +47.99% | -115.0M +24.84% | -92.1M +26.25% | -72.9M +18.77% | |
Interest Income | 4.1M -1.95% | 4.1M -33.23% | 6.2M +411.44% | 1.2M +571.27% | |
Interest Expense | -1.1M -75.05% | -4.6M +10.22% | -4.1M +93.68% | -2.1M -78.57% | |
Interest Income and Expense and Net | 2.9M +809.44% | -413,000 -119.90% | 2.1M +325.05% | -922,000 -90.58% | |
Total Nonoperating Income and Expense | -203,000 +65.04% | -123,000 +12.84% | -109,000 -331.91% | 47,000 +103.58% | |
Income before Taxes | -209.5M +60.57% | -130.5M +41.67% | -92.1M +24.75% | -73.8M +3.67% | |
Income Taxes | 185,000 0.00% | 185,000 N/A | N/A N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | 0 N/A | |
Net Income | -209.5M +60.35% | -130.6M +49.53% | -87.4M +18.36% | -73.8M +3.67% | |
Net Income from Continuing Operations Applicable to Common | -209.5M +60.57% | -130.5M +49.31% | -87.4M +18.36% | -73.8M +3.67% | |
Basic EPS and Net Income | -3.02 -17.49% | -3.66 -7.58% | -3.96 +942.11% | -0.38 -7.32% | |
Diluted EPS and Net Income | -3.02 -17.49% | -3.66 -6.87% | -3.93 +934.21% | -0.38 -7.32% | |
Basic Weighted Average Shares | 69.3M +94.07% | 35.7M +61.93% | 22.1M -88.61% | 193.7M +11.04% | |
Diluted Weighted Average Shares | 69.3M +94.07% | 35.7M +61.93% | 22.1M +11,288.35% | 193,654 -99.89% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 205.0M +130.80% | 88.8M +14.00% | 77.9M +3.97% | 74.9M +252.59% | |
Short-Term Investments | N/A N/A | 59.2M 0.00% | 59.2M +356.91% | 13.0M -83.59% | |
Cash and Cash Equivalents and Short-Term Investments | 205.0M +38.47% | 148.0M +7.96% | 137.1M +56.02% | 87.9M -12.33% | |
Total Current Assets | 223.4M +135.27% | 95.0M -33.91% | 143.7M +54.71% | 92.9M -12.17% | |
Accumulated Depreciation | 1.6M +0.25% | 1.6M +1.63% | 1.6M +4.05% | 1.5M -8.66% | |
Property and Plant and Equipment and Net | 32,000 0.00% | 32,000 -13.51% | 37,000 -59.78% | 92,000 -56.19% | |
Total Long-Term Assets | 6.1M +24.76% | 4.9M +6.80% | 4.6M +7,808.62% | 58,000 -65.68% | |
Total Assets | 246.4M +142.71% | 101.5M -32.18% | 149.7M +57.51% | 95.0M -12.53% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | 275,000 0.00% | 275,000 N/A | |
Total Current Liabilities | 72.3M +133.33% | 31.0M +17.41% | 26.4M +21.77% | 21.7M +16.53% | |
Total Long-Term Debt | 76.3M +87.43% | 40.7M +1.59% | 40.1M +61.80% | 24.8M +9,849.80% | |
Total Long-Term Liabilities | 36.2M -38.40% | 58.7M +10,981.89% | 530,000 -63.95% | 1.5M -35.07% | |
Total Liabilities | 189.2M +45.09% | 130.4M +83.23% | 71.2M +49.36% | 47.7M +125.84% | |
Retained Earnings | -1.2B +21.92% | -955.5M +15.84% | -824.9M +11.85% | -737.5M +11.12% | |
Total Stockholders Equity | 57.2M +297.96% | -28.9M -150.36% | 57.4M +21.07% | 47.4M -45.88% | |
Total Shares Outstanding | 77.7M +73.59% | 44.8M +77.14% | 25.3M -87.39% | 200.5M +8.23% | |
Cash Flow | |||||
Cash from Operating Activities | -137.5M +31.25% | -104.8M +21.18% | -86.5M +35.79% | -63.7M +19.01% | |
Capital Expenditures | 28,000 0.00% | 28,000 -85.71% | 196,000 0.00% | 196,000 0.00% | |
Cash from Investing Activities | -9.6M -116.05% | 60.0M +234.93% | -44.4M -167.16% | 66.2M +75,974.71% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 263.3M +380.64% | 54.8M -59.18% | 134.2M +159.14% | 51.8M +652.13% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -550.33% -52.13% | -1,149.56% -67.59% | -3,547.15% +26.25% | -2,809.59% -6.07% | |
Return on Assets | -120.39% +15.78% | -103.99% +45.67% | -71.39% -1.49% | -72.47% +33.85% | |
Return on Equity | -1,480.15% +61.35% | -917.36% +450.02% | -166.79% +52.47% | -109.39% +55.82% | |
Revenue Growth | 209.14% -26.67% | 285.21% N/A | 0.00% -100.00% | 26.45% +127.08% | |
Current Ratio | 3.09 +0.83% | 3.07 -43.71% | 5.45 +27.05% | 4.29 -24.63% | |
Cash Ratio | 2.84 -1.08% | 2.87 -2.90% | 2.95 -14.62% | 3.46 +202.57% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | 0.70 +33.09% | 0.53 N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | 0.27 +2.31% | 0.26 N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow